Cyanotech Corporation (CYAN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cyanotech Corporation (CYAN) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-65.00K) by net assets ($7.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cyanotech Corporation - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Cyanotech Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CYAN current and long-term liabilities for a breakdown of total debt and financial obligations.
Cyanotech Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cyanotech Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rakovina Therapeutics Inc
V:RKV
|
-0.548x |
|
Winchester Energy Ltd
AU:WEL
|
-0.014x |
|
KEY Petroleum Ltd
AU:KEY
|
-0.230x |
|
Sentul City Tbk
JK:BKSL
|
0.030x |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
N/A |
|
Mantex AB
ST:MANTEX
|
0.076x |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
-0.008x |
|
Bounty Oil & Gas NL
AU:BUY
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Cyanotech Corporation (1991–2025)
The table below shows the annual cash flow conversion efficiency of Cyanotech Corporation from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Cyanotech Corporation (CYAN) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $8.88 Million | $-1.19 Million | -0.134x | -248.67% |
| 2024-03-31 | $11.81 Million | $-455.00K | -0.039x | +70.02% |
| 2023-03-31 | $16.35 Million | $-2.10 Million | -0.128x | -205.23% |
| 2022-03-31 | $19.49 Million | $2.38 Million | 0.122x | -13.32% |
| 2021-03-31 | $17.04 Million | $2.40 Million | 0.141x | +79.54% |
| 2020-03-31 | $15.85 Million | $1.24 Million | 0.078x | +238.08% |
| 2019-03-31 | $14.91 Million | $-847.00K | -0.057x | -169.04% |
| 2018-03-31 | $18.11 Million | $1.49 Million | 0.082x | +12.01% |
| 2017-03-31 | $16.61 Million | $1.22 Million | 0.073x | +75.80% |
| 2016-03-31 | $17.83 Million | $745.00K | 0.042x | -27.54% |
| 2015-03-31 | $21.48 Million | $1.24 Million | 0.058x | -44.05% |
| 2014-03-31 | $20.85 Million | $2.15 Million | 0.103x | +9.92% |
| 2013-03-31 | $20.23 Million | $1.90 Million | 0.094x | -71.83% |
| 2012-03-31 | $15.27 Million | $5.08 Million | 0.333x | +111.74% |
| 2011-03-31 | $11.11 Million | $1.75 Million | 0.157x | +17.63% |
| 2010-03-31 | $9.12 Million | $1.22 Million | 0.134x | +14.44% |
| 2009-03-31 | $7.77 Million | $908.00K | 0.117x | +195.28% |
| 2008-03-31 | $6.38 Million | $-782.00K | -0.123x | -100.58% |
| 2007-03-31 | $7.51 Million | $-459.00K | -0.061x | -605.92% |
| 2006-03-31 | $14.82 Million | $179.00K | 0.012x | -86.28% |
| 2005-03-31 | $15.08 Million | $1.33 Million | 0.088x | -35.32% |
| 2004-03-31 | $14.44 Million | $1.97 Million | 0.136x | +432.86% |
| 2003-03-31 | $12.27 Million | $-502.00K | -0.041x | +4.84% |
| 2002-03-31 | $13.19 Million | $-567.00K | -0.043x | -377.63% |
| 2001-03-31 | $15.70 Million | $243.00K | 0.015x | -24.87% |
| 2000-03-31 | $16.64 Million | $343.00K | 0.021x | +147.40% |
| 1999-03-31 | $20.70 Million | $-900.00K | -0.043x | -200.87% |
| 1998-03-31 | $23.20 Million | $1.00 Million | 0.043x | -65.37% |
| 1997-03-31 | $23.30 Million | $2.90 Million | 0.124x | -17.18% |
| 1996-03-31 | $17.30 Million | $2.60 Million | 0.150x | -23.35% |
| 1995-03-31 | $5.10 Million | $1.00 Million | 0.196x | +37.25% |
| 1994-03-31 | $4.20 Million | $600.00K | 0.143x | -28.57% |
| 1993-03-31 | $1.50 Million | $300.00K | 0.200x | +320.00% |
| 1992-03-31 | $1.10 Million | $-100.00K | -0.091x | +72.73% |
| 1991-03-31 | $1.50 Million | $-500.00K | -0.333x | -- |
About Cyanotech Corporation
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to… Read more